The Response of Variant Histology Bladder Cancer to Intravesical Immunotherapy Compared to Conventional Cancer

BACKGROUND: High-grade urothelial carcinomas (UCs) often show foci of variant differentiation. There is limited information in the literature about the response of these variant urothelial tumors to immunotherapy with bacillus Calmette–Guerin (BCG). We compared the response, to treatment with BCG, o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Gofrit, Ofer N., Yutkin, Vladimir, Shapiro, Amos, Pizov, Galina, Zorn, Kevin C., Hidas, Guy, Gielchinsky, Ilan, Duvdevani, Mordechai, Landau, Ezekiel H., Pode, Dov
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2016
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4791377/
https://ncbi.nlm.nih.gov/pubmed/27014622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2016.00043
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars